C
CABA
Cabaletta Bio, Inc.
3.070
+0.060+1.99%After Hours: 3.150 +0.080 +2.61%19:55 04/07 EDT
OPEN/PREV CLOSE3.180/3.070
TODAY RANGE3.040-3.240
VOL1.43M
MARKET CAP343.99M
52 WEEK RANGE0.9857-3.780
AVG VOL (3M)3.08M
% TURNOVER1.28%
TURNOVER--
P/E (TTM)-1.4709
% RANGE6.51%
EPS(TTM)-2.1007
P/E(FORWARD)-2.0329
P/B2.771
BVPS1.115
DIVIDEND--
P/S2,859.09
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP338.97M
SHARES OUTSTANDING111.32M
NEXT EARNINGS05/13-05/18
FREE FLOAT109.70M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·2d ago
H.C. Wainwright Remains a Buy on Cabaletta Bio (CABA)
Benzinga·03/24 13:40
Pfizer To Rally More Than 34%? Here Are 10 Top Analyst Forecasts For Tuesday
Dow Jones·03/24 13:37
Cabaletta Bio Price Target Cut to $13.00/Share From $14.00 by Morgan Stanley
Dow Jones·03/24 13:37
Cabaletta Bio Is Maintained at Overweight by Morgan Stanley
Dow Jones·03/24 13:31
Cabaletta Bio Is Maintained at Buy by Guggenheim
Dow Jones·03/24 13:31
Cabaletta Bio Price Target Raised to $16.00/Share From $15.00 by Guggenheim
Benzinga·03/24 13:27
Morgan Stanley Maintains Overweight on Cabaletta Bio, Lowers Price Target to $13
Benzinga·03/24 13:20
Guggenheim Maintains Buy on Cabaletta Bio, Raises Price Target to $16
TipRanks·03/24 11:26
Wells Fargo Issues a Hold Rating on Cabaletta Bio (CABA)
Simply Wall St·03/24 10:03
Will Cabaletta Bio (NASDAQ:CABA) Spend Its Cash Wisely?
TipRanks·03/23 23:20
Cabaletta Bio price target lowered to $13 from $14 at Morgan Stanley
Same Industry
Name/Symbol
Change%
Price